Prochlorperazine Edisylate
- Product NDC
- 70860-778
- 11-digit product format
- 708600778
- Labeler code
- 70860
- Product ID
- 70860-778_0a1bce3b-675f-420b-a8fd-a93bde270753
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- prochlorperazine edisylate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA040540
- Marketing category
- ANDA
- Marketing start
- 2018-11-08
- Marketing end
- 0000-00-00
- Substance
- PROCHLORPERAZINE EDISYLATE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Phenothiazine [EPC], Phenothiazines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-778-02 | 70860077802 | 10 VIAL in 1 CARTON (70860-778-02) > 2 mL in 1 VIAL (70860-778-41) | 10 vial | 2018-11-08 | 0000-00-00 | No | No | Current |
| 70860-778-10 | 70860077810 | 1 VIAL, MULTI-DOSE in 1 CARTON (70860-778-10) > 10 mL in 1 VIAL, MULTI-DOSE | | 2018-11-08 | 0000-00-00 | No | No | Current |